Skip to main content

Table 2 Biomarkers in acute kidney injury a

From: Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study

 

Non-AKI ( N  = 56)

AKI ( N  = 42)

P -value

Plasma NGAL (ng/ml)

80 (60 to 142)

322 (157 to 540)

<0.0001

Plasma IL-6 (pg/ml)

45.1 (22.9 to 226.3)

322.4 (70.3 to 5150.6)

0.0002

Plasma EPO (mIU/ml)

16.1 (9.9 to 28.5)

27.8 (10.2 to 106.0)

0.02

Urinary TIMP-2 (ng/ml)

2.08 (0.72 to 4.59)

10.85 (2.23 to 34.60)

<0.0001

Urinary NAG (U/L)

5.9 (3.1 to 15.0)

31.8 (14.1 to 71.4)

<0.0001

  1. aAKI, Acute kidney injury; EPO, Erythropoietin; IL, Interleukin; NAG, N-acetyl-β-d-glucosaminidase; NGAL, Neutrophil gelatinase-associated lipocalin; TIMP-2, Tissue inhibitor of matrix metalloproteinase-2.
Back to article page

Critical Care

ISSN: 1364-8535